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extended whole mediastinal proton-beam
irradiation for esophageal cancer
Noriyuki Okonogi1,2*, Takatuki Hashimoto1, Masaya Ishida1, Toshiki Ohno1, Toshiyuki Terunuma1,
Toshiyuki Okumura1, Takeji Sakae1 and Hideyuki Sakurai1Abstract
Background: Proton-beam therapy (PBT) provides therapeutic advantages over conformal x-ray therapy in sparing
organs at risk when treating esophageal cancer because of the fundamental physical dose distribution of the
proton-beam. However, cases with extended esophageal lesions are difficult to treat with conventional PBT with a
single isocentric field, as the length of the planning target volume (PTV) is longer than the available PBT field size in
many facilities. In this study, the feasibility of a practical technique to effectively match PBT fields for esophageal
cancer with a larger regional field beyond the available PBT field size was investigated.
Methods: Twenty esophageal cancer patients with a larger regional field than the available PBT single-field size
(15 cm in our facility) were analyzed. The PTV was divided into two sections to be covered by a single PBT field.
Subsequently, each PTV isocenter was aligned in a cranial-caudal (CC) axis to rule out any influence by the
movement of the treatment couch in anterior-posterior and left-right directions. To obtain the appropriate dose
distributions, a designed-seamless irradiation technique (D-SLIT) was proposed. This technique requires the following
two adjustments: (A) blocking a part of the PTV by multi-leaf collimator(s) (MLCs); and (B) fine-tuning the isocenter
distance by the half-width of the MLC leaf (2.5 mm in our facility). After these steps, the inferior border of the cranial
field was designed to match the superior border of the caudal field. Dose distributions along the CC axis around the
field junction were evaluated by the treatment-planning system. Dose profiles were validated with imaging plates in
all cases.
Results: The average and standard deviation of minimum dose, maximum dose, and dose range between maximum
and minimum doses around the field junction by the treatment-planning system were 95.9 ± 3.2%, 105.3 ± 4.1%,
and 9.4 ± 5.2%. The dose profile validated by the imaging plate correlated with the results of the treatment-planning
system in each case, with an error range within 4.3%.
Conclusions: Dose distributions around the field junction were applied using D-SLIT. D-SLIT can be a useful
treatment strategy for PBT of extended esophageal cancer.
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Proton-beam therapy (PBT) appears to provide distinct
therapeutic advantages over conformal x-ray therapy in
sparing organs at risk (OAR) when treating esophageal
cancer [1,2]. These advantages are based on the funda-
mental physical dose distribution of the proton-beam
[3]. However, cases with extended esophageal lesions or
with distant regional lymph node metastases are hard to
treat with conventional PBT with a single isocentric
field. This is mainly due to the fact that the length of the
planning target volume (PTV) is longer than the avail-
able field size of PBT in many facilities.
On the other hand, some studies have reported so-
called ‘patch-field’ strategies for tumors with highly com-
plex shapes (e.g., a target coverage wrapped around a
critical structure) in PBT [4,5]. These strategies were
used to confirm dose delivery to the target and spare
OAR. In principle, target regions are divided into seg-
ments, each treated by a separate proton field. Subse-
quently, the distal edge of one field is matched with the
lateral field edge of the second field. However, few stud-
ies have reported a long field for such extended esopha-
geal cancer.
The present study investigated the feasibility of a prac-
tical technique to effectively match PBT fields along the
lateral edge for esophageal cancer with larger regional
fields beyond the available PBT field size.
Methods
Therapy beams and systems
The PBT system used consists of an isocentric rotational
gantry equipped with an x-ray imager, a rotational treat-
ment couch, a treatment-planning system (HITACHI
3D Treatment-planning system version 1.72, Tokyo,
Japan), a treatment-planning computed tomography
(CT) scanner, and an x-ray simulator without anyFigure 1 Definition of PTV. CTV included the primary tumor plus a 30-mm
plus a 10-mm margin. PTV encompassed the CTV with a 5- to 10-mm marg
single PBT field: cranial PTV and caudal PTV.system modification [6]. System precision studies were
carried out in order to ensure that there was no devi-
ation of the isocenter while moving the treatment couch
loaded with a 60-kg phantom.
Treatment was delivered via 200 MeV proton beams
during the end-expiratory phase using a respiratory gat-
ing system (Anzai Medical Co., Tokyo, Japan) [7]. The
patient’s body was immobilized using an individually
shaped body cast (ESFORM; Engineering System Co.,
Matsumoto, Japan). Respiratory gating was controlled by
laser range finder monitoring the movement of the
patient’s body surface.
Treatment-planning methods of D-SLIT
The present study proposes the novel ‘Designed-
Seamless Irradiation Technique (D-SLIT)’ for longitu-
dinally extended PTV in PBT. The procedures for this
technique are described below.
Acquiring CT images at 5-mm intervals during the
expiratory phase under a respiratory gating system
All images were used to design treatment plans by a sin-
gle treatment-planning system.
After delineation the PTV was divided into two sections
covered by a single PBT field (cranial PTV and caudal PTV
(Figure 1))
In this study, target volumes were defined and deli-
neated in a self-consistent manner in order to reduce
biases. Gross tumor volume was defined as the volume
of a primary tumor demonstrated by CT and endoscopy,
as well as metastatic lymph nodes that measured ≥10
mm in the long axis. The clinical target volume (CTV)
included the primary tumor plus a 30-mm cranial-caudal
margin, and included the metastatic lymph nodes plus a
10-mm margin [8]. PTV encompassed the CTV with acranial-caudal margin, and included the metastatic lymph nodes
in in all directions. PTV was divided into two sections covered by a
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the cranial-caudal direction).Each PTV isocenter was aligned along the CC axis
Two PTV isocenters were aligned on the cranial-caudal
(CC) axis in order to avoid any influence by the move-
ment of the treatment couch in the anterior-posterior
and left-right directions. In this study, each plan
included two co-planar, equally weighted beams placed
at gantry angles of 0° and 180° for each PTV. An additional
10-mm margin was included to cover each PTV by
enlarging the multi-leaf collimator (MLC) and adjusting
the range shifter. The snout is close to the patient in the
treatment-planning system and hence reduces lateral
penumbra of proton beams, in principle.Blocking part of the PTV by movement of the MLC and
fine-tuning the isocenter distance
Proton beams have a few inherent lateral penumbras.
Therefore, the risk of hot or cold spots around the
field junction cannot be avoided. To minimize such hot
and cold spots, fine-tuning is required (Figure 2). In
order to obtain acceptable dose distribution, at first,
one or two MLC leaves were moved to block part of
the PTV at the junction in both the anterior-posterior
(AP) and posterior-anterior (PA) directions. After
checking dose distribution in several patterns, the most
acceptable pattern (e.g., 5-mm blocking in the AP field
and 10-mm blocking in the PA field) was selected
(Figure 2A). Secondly, the isocenter distance was fine-
tuned by the half-width of the MLC leaf (2.5 mm in
our facility) for further homogeneities at the field junc-
tion (Figure 2B).Figure 2 D-SLIT fine-tuning. The two figures show beam’s eye view-shap
avoid hot spots around the junction, a part of the PTV was blocked by the
fine-tuned by 2.5 mm (half-width of the MLC leaf in our facility).Patient selection
This study was conducted in accordance with the ethical
standards defined in the Declaration of Helsinki. PBT for
esophageal cancer was approved by the ethics committee
of the University of Tsukuba. A total of 20 cases from
our institutional records were analyzed in this study. All
patients had middle thoracic esophageal cancer, and
gastro-esophageal junction cancers were not included.
All patients provided written informed consent after a
comprehensive discussion covering the nature of their
illness, other therapeutic options, and potential adverse
effects. Eight of the 20 cases were finally irradiated with
D-SLIT. The remaining 12 cases only underwent simu-
lated D-SLIT based on previously acquired CT.Actual treatment of eight patients with on-going
planning
The photon equivalent dose (Gray equivalent dose; GyE)
was defined as the physical dose (Gy) × the relative bio-
logical effectiveness of the proton beam. Based on the
biological response of salivary gland tumor cells, the
relative biological effectiveness of the proton beam was
assigned a value of 1.1. The planned total doses were
60.0 to 70.0 GyE (median, 60.0 GyE), at 2.0 GyE per
fraction. This was the common radiation dose and frac-
tionation schedule for esophageal cancer patients treated
with PBT in our institute. Field junctions were shifted
twice along the CC direction.Evaluation methods
For evaluation of the feasibility of this technique, the
dose distributions and profiles along the CC axis around
the field junction were compared in the treatment-
planning system. Regarding dose profiles, the averageed fields designed to match the cranial field and caudal field. (A) To
MLC. (B) To reduce hot or cold spots, the isocenter distance was
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imum dose, and dose range between the maximum and
minimum dose were evaluated. Additionally, the in-
homogeneous, non-uniform dose distribution range
around the field junction, termed the ‘discordant dis-
tance’, was evaluated (Figure 3). Imaging plates (IP)
consisting of storage films coated with photostimulated
phosphor were used for validation of dose profiles.
Adverse events of the eight patients receiving PBT were
evaluated by an outpatient clinician using Common
Terminology Criteria for Adverse Events (CTCAE)
version 4.0.
Results
All 20 cases were planned with D-SLIT. It usually took
an extra 2–3 hours to produce a D-SLIT plan in each
case. Target volumes were covered well in all plans.
Physical characteristics of the proton beam resulted in a
lower dose to a particular OAR, such as the lung, heart
or spinal cord. A representative case of dose distribution
by the PBT plan with D-SLIT is presented in Figure 3.
Although a slightly hot region was seen in front of the
vertebral body, the dose distribution around the field
junction was almost homogeneous. On the other hand,Figure 3 D-SLIT dose distribution and profile. (Left) The upper figure sh
PTV appears white in the axial view. Dose distributions in percentages (10-
profile along the CC axis on the isocenter line. (Right) Enlarged dose profile
discordant distance were calculated by treatment-planning system. To calc
spreadsheet. At first, the dose increasing/decreasing region over 2% was ex
Secondly, the starting points of does change in those regions were detecte
points was calculated as the discordant distance.the spinal cord received less than 60% of the prescribed
dose and a small volume of the lung received approxi-
mately 20% of the prescribed dose. Figure 4A shows a
distribution chart of the minimum and maximum doses,
and Figure 4B shows the average ± S.D. of PTV length,
minimum dose, maximum dose, dose range, and dis-
cordant distance around the field junction along the CC
axis on the isocenter line. Only one case was outside the
minimum dose distribution chart, with 84.8% of the
prescribed dose. The average and S.D. in minimum
dose, maximum dose, and dose range were 95.9 ± 3.2%,
105.3 ± 4.1%, and 9.4 ± 5.2%, respectively. The average ±
S.D. of the discordant distance was 10.6 ± 4.2 mm.
Nine patients presented with Dmax >107% and five
patients presented with Dmin <95% (Table 1). The
dose profile validated by IP correlated with the result
of the dose profile in the treatment-planning system
for each case, and the error range was within 4.3%
(Figure 5). The 20-80% penumbra width within the re-
gion of the spread out Bragg peak was approximately
7 to 8 mm using 200 MeV protons in this study. To
avoid hot or cold spots around the junction, the field
junctions were sifted by 15–20 mm twice during an
entire treatment course in eight patients treated withows dose distribution with D-SLIT in the axial view and sagittal view.
105%) are shown in the left bar chart. The lower figure shows the dose
around the field junction. Minimum dose, maximum dose, and
ulate discordant distance, all dose profiles were exported to a
tracted at intervals of 3-mm on the dose profile around field junction.
d with 0.1-mm resolution. Then, the distance between two furthest
Figure 4 Results of average and standard deviation with D-SLIT. (A) Distributions of minimum dose and maximum dose in all 20 cases. Each
cross symbol shows the dose in each case. Open symbols represent average doses. (B) Average and standard deviation with D-SLIT.
Table 1 Dosimetric results in 20 cases
Case No. Length of PTV (mm) Minimum dose (%) Maximum dose (%) Discordant distance (mm) Homogeneityindex of PTV
1 240 95.6 107.3 18.1 1.12
2 195 95.3 101.9 11.3 1.07
3 230 95.4 101.0 9.5 1.06
4 190 97.7 108.2 13.3 1.11
5 200 96.4 101.1 2.9 1.05
6 190 99.5 108.7 12.9 1.09
7 170 99.5 106.3 14.8 1.07
8 190 97.8 100.0 5.0 1.02
9 210 95.9 101.4 8.1 1.06
10 220 94.8 108.9 14.3 1.15
11 165 97.0 109.2 12.5 1.13
12 215 93.7 100.3 9.3 1.07
13 230 94.8 102.8 10.9 1.08
14 230 84.8 109.8 15.9 1.29
15 245 98.2 111.9 12.8 1.14
16 190 96.5 101.2 3.0 1.05
17 210 98.9 111.4 13.0 1.13
18 165 95.7 105.9 11.0 1.11
19 220 97.4 101.2 5.0 1.04
20 220 93.1 107.3 8.8 1.15
Average 206.3 95.9 105.3 10.6 1.10
S.D. 24.0 3.2 4.1 4.2 0.1
Abbreviations: No.; number, PTV; planning target volume, S.D.; standard deviation.
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Figure 5 Comparison of dose distributions between the
treatment-planning system and imaging plate. Dose distribution
by the treatment-planning system and imaging plate (IP) along
the CC axis on the isocenter line. White bars show the
treatment-planning system, and gray bars show the imaging plate.
The dose ‘gap’ between the treatment-planning system and IP was
up to 4.3%.
Okonogi et al. Radiation Oncology 2012, 7:173 Page 6 of 7
http://www.ro-journal.com/content/7/1/173D-SLIT. Acute toxicity could be evaluated in these
patients, and grade ≥3 treatment-related toxicity was
not observed around the field junction (unpublished data).
Discussion
Esophageal cancer is the eighth most common cancer in
Japan [9]. Despite modern multimodality therapy,
esophageal cancer still has a poor prognosis [10]. Surgi-
cal therapy remains the mainstay of curative therapy for
esophageal cancer. However, many patients with esopha-
geal cancer are diagnosed at an advanced, inoperable
stage. Furthermore, some patients may be deemed un-
suitable for surgery because of co-morbidity or increas-
ing age [11]. On the other hand, some studies have
reported that definitive chemoradiotherapy (CRT) is an
effective alternative to surgical therapy and can achieve
long-term disease control, with the overall 5-year sur-
vival rate reaching 20-27% for locally advanced esopha-
geal cancer [12,13].
Conventional CRT for advanced esophageal cancer is
generally challenging because of the surrounding radio-
sensitive organs such as the lung, and the proximity of
critical structures such as the heart and spinal cord. In
order to reduce the risk of morbidity in these organs,
PBT has advantages based on the fundamental physical
dose distribution [3]. As described above, however, the
available field size of PBT is insufficient to treat locally
advanced esophageal cancer existing as an extended
esophageal lesion. Field sizes up to 25 × 25 cm2 can be
achieved with the double scattering system [14]. This
problem is common to many facilities.
On the other hand, the so-called ‘patch-field’ tech-
nique has been introduced in several studies [4,5,15,16].
This technique is used to optimize dose distribution
within an irregular volume in close proximity to critical
normal structures. Hug et al. reported excellent sparingof the lens and selected intraorbital and ocular normal
structures, while maintaining conformal dose-target
coverage in orbital rhabdomyosarcoma of children [4].
According to their report, the target volume was divided
into two segments, each treated by a separate radiation
field. Utilizing sharp dose distribution, the distal edge of
one field was matched with the lateral field edge of the
second field while taking care to avoid match lines in
critical structures. In fact, this method provided long
disease-free periods, without severe morbidity.
In the present study, the distal or cranial field edge of
one field was matched with that of the other field. To
date, several studies concerning PBT for esophageal can-
cer have been reported, and to our knowledge, this study
is the first report on PBT using ‘patch-field’ technique
for esophageal cancer. Traditionally, distal-cranial
matching has been used for craniospinal irradiation with
photons as well as other diseases [17,18]. However, hot
or cold spots around the field junction cannot be
avoided. On the other hand, in the present study, the
average minimum dose and maximum dose was between
95.9% and 105.3% around the field junction along the
CC axis by the treatment-planning system. This result is
acceptable compared with the dose homogeneities of
previous reports using the ‘patch-field’ technique [4,5],
and satisfies the criteria of the International Commission
on Radiation Units reports 50 and 62 [19,20].
In some cases in the present report, hot or cold spots
were actually present in the target volume around the
field junction. Passing through highly complex heteroge-
neities and some minor inherent lateral penumbra of
protons could have caused the dose distribution at the
field junction to be non-uniform. Therefore, shifting the
field junction should be considered to avoid over- or
under-dosage. In the present study, the average ± S.D. of
discordant distance was 10.6 ± 4.2 mm. From these
results, it seems necessary to slide the field junction by
at least 19.0 mm (two-sided 95% confidence interval).
The present study has several limitations. In particular,
the effects of respiratory and peristaltic motions on the
esophagus were not well considered. Yaremko et al.
reported esophageal motion using respiratory-gated
four-dimensional CT [21]. In their study, the mean of
peak-to-peak displacement of the esophagus was 7.1 mm
in the CC axis in 31 consecutive patients treated for
esophageal cancer. Although the present report used
CT images obtained during the expiratory phase
under a respiratory gating system, it is insufficient to
evaluate motion of the esophagus within the expira-
tory phase and to evaluate peristaltic motion during
treatment. Shifting the field junction several times is
one possible way to avoid the uncertainty due to
these motions in clinical practice. Further physical
and clinical studies are needed.
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Dose distributions around the field junction were deter-
mined using D-SLIT. D-SLIT might represent a novel
and safe therapeutic option for locally advanced esopha-
geal cancer. Although further physical and clinical stud-
ies are needed to confirm the effects of D-SLIT, this
approach might be a useful treatment strategy for PBT
of extended esophageal cancer.
Abbreviations
PBT: Proton-beam therapy; PTV: Planning target volume; CC: Cranial-caudal;
D-SLIT: Designed-seamless irradiation technique; MLC: Multi-leaf collimator;
OAR: Organs at risk; CT: Computed tomography; CTV: Clinical target volume;
AP: Anterior-posterior; PA: Posterior-anterior; IP: Imaging plate;
CRT: Chemoradiotherapy.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
TH and HS coordinated the entire study. Patient clinical data collection was
done by NO and TO (4th author). Treatment planning was conducted by
NO, TH and TO (4th author). Data collection of dose profile was worked out
by MI and TT. Data analysis was done by NO, MI and TS. The manuscript was
prepared by NO. Corrections and/or improvements were suggested by TH,
TO (6th author) and TS. Major revisions were done by HS. All authors read
and approved the final manuscript.
Acknowledgments
The authors thank the technical staff operating the Proton Medical Research
Center, University of Tsukuba for their generous support of our experiments.
This research is partly supported by the “Funding Program for World-Leading
Innovative R&D on Science and Technology (FIRST Program),” initiated by the
Council for Science and Technology Policy (CSTP).
Received: 7 July 2012 Accepted: 13 October 2012
Published: 19 October 2012
References
1. Isacsson U, Lennernäs B, Grusell E, Jung B, Montelius A, Glimelius B:
Comparative treatment planning between proton and x-ray therapy in
esophageal cancer. Int J Radiat Oncol Biol Phys 1998, 41:441–450.
2. Zhang X, Zhao KL, Guerrero TM, McGuire SE, Yaremko B, Komaki R, Cox JD,
Hui Z, Li Y, Newhauser WD, Mohan R, Liao Z: Four-dimensional computed
tomography-based treatment planning for intensity-modulated radiation
therapy and proton therapy for distal esophageal cancer. Int J Radiat
Oncol Biol Phys 2008, 72:278–287.
3. Pedroni E, Bacher R, Blattmann H, Böhringer T, Coray A, Lomax A, Lin S,
Munkel G, Scheib S, Schneider U: The 200-Mev proton therapy project at
the Paul Scherrer Institute: Conceptual design and practical realization.
Med Physics 1995, 22:37–53.
4. Hug EB, Adams J, Fitzek M, De Vries A, Munzenrider JE: Fractionated, three-
dimensional, planning-assisted proton-radiation therapy for orbital
rhabdomyosarcoma: a novel technique. Int J Radiat Oncol Biol Phys 2000,
47:979–984.
5. Li Y, Zhang X, Dong L, Mohan R: A novel patch-field design using an
optimized grid filter for passively scattered proton beams. Phys Med Biol
2007, 52:265–275.
6. Tsunashima Y, Sakae T, Shioyama Y, Kagei K, Terunuma T, Nohtomi A, Akine Y:
Correlation between the respiratory waveform measured using a
respiratory sensor and 3D tumor motion in gated radiotherapy. Int J Radiat
Oncol Biol Phys 2004, 60:951–958.
7. Ohara K, Okumura T, Akisada M, Inada T, Mori T, Yokota H, Calaguas MJ:
Irradiation synchronized with respiration gate. Int J Radiat Oncol Biol Phys
1989, 17:853–857.
8. Kato K, Muro K, Minashi K, Ohtsu A, Ishikura S, Boku N, Takiuchi H, Komatsu Y,
Miyata Y, Fukuda H, astrointestinal Oncology Study Group of the Japan
Clinical Oncology Group (JCOG): Phase II study of chemoradiotherapy with
5-fluorouracil and cisplatin for Stage II-III esophageal squamous cellcarcinoma: JCOG trial (JCOG 9906). Int J Radiat Oncol Biol Phys 2011,
81:684–690.
9. Matsuda T, Marugame T, Kamo K, Katanoda K, Ajiki W, Sobue T, Japan
Cancer Surveillance Research Group: Cancer Incidence and Incidence
Rates in Japan in 2006: Based on Data from 15 Population-based Cancer
Registries in the Monitoring of Cancer Incidence in Japan (MCIJ) Project.
Jpn J Clin Oncol 2012, 42:139–147.
10. Enzinger PC, Mayer RJ: Esophageal cancer. N Engl J Med 2003,
349:2241–2252.
11. Harrison LE: Is esophageal cancer a surgical disease? J Surg Oncol 2011,
75:227–231.
12. Gwynne S, Hurt C, Evans M, Holden C, Vout L, Crosby T: Definitive
chemoradiation for oesophageal cancer, a standard of care in patients
with non-metastatic oesophageal cancer. Clin Oncol 2011, 23:182–188.
13. Al-Sarraf M, Martz K, Herskovic A, Leichman L, Brindle JS, Vaitkevicius VK,
Cooper J, Byhardt R, Davis L, Emami B: Progress report of combined
chemoradiotherapy versus radiotherapy alone in patients with
esophageal cancer: an intergroup study. J Clin Oncol 1997, 15:277–284.
14. Smith A, Gillin M, Bues M, Zhu XR, Suzuki K, Mohan R, Woo S, Lee A, Komaki
R, Cox J, Hiramoto K, Akiyama H, Ishida T, Sasaki T, Matsuda K: The M. D.
Anderson proton therapy system. Med Phys 2009, 36:4068–4083.
15. Bussière MR, Adams JA: Treatment planning for conformal proton
radiation therapy. Technol Cancer Res Treat 2003, 2:389–399.
16. Bortfeld T, Paganetti H, Kooy H: Proton beam radiotherapy-the state of
the art. Med Phys 2005, 32:2048–2059.
17. Hawkins RB: A simple method of radiation treatment of craniospinal
fields with the patient supine. Int J Radiat Oncol Biol Phys 2001,
49:261–264.
18. Parker WA, Freeman CR: A simple technique for craniospinal radiotherapy
in the supine position. Radiother Oncol 2006, 78:217–222.
19. International Commission on Radiation Units and Measurements.
Prescribing, recording, and reporting photon beam therapy: ICRU Report 50.
Bethesda, MD: ICRU; 1993.
20. International Commission on Radiation Units and Measurements.
Prescribing, recording, and reporting photon beam therapy: ICRU Report 62;
supplement to ICRU Report 50. Bethesda, MD: ICRU; 1999.
21. Yaremko BP, Guerrero TM, McAleer MF, Bucci MK, Noyola-Martinez J,
Nguyen LT, Balter PA, Guerra R, Komaki R, Liao Z: Determination of
respiratory motion for distal esophagus cancer using four-dimensional
computed tomography. Int J Radiat Oncol Biol Phys 2008, 70:145–153.
doi:10.1186/1748-717X-7-173
Cite this article as: Okonogi et al.: Designed-seamless irradiation
technique for extended whole mediastinal proton-beam irradiation for
esophageal cancer. Radiation Oncology 2012 7:173.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
